美国产后静脉血栓栓塞症预防资格中的种族和民族差异
该研究分析美国全国住院患者样本2015年10月至2019年12月的数据,按种族和民族分层比较产后静脉血栓栓塞症预防资格的比例。根据RCOG、ACCP、ACOG和美国血液学会指南,符合预防资格的比例分别为32.9%、8.0%、0.2%和0.2%。使用RCOG标准,非西班牙裔黑人个体预防资格比例最高(39.7%),西班牙裔个体最低(30.8%)。
要点
- 产后静脉血栓栓塞症预防资格比例因指南而异,RCOG标准为32.9%,ACCP为8.0%,ACOG和美国血液学会均为0.2%。
- 使用RCOG标准,非西班牙裔黑人个体预防资格比例最高(39.7%),西班牙裔个体最低(30.8%)。
- 种族差异主要由临床风险因素(非西班牙裔黑人38.8% vs 西班牙裔30.5%)和剖宫产率(35.9% vs 32.2%)驱动。
核心结论
- 非西班牙裔黑人个体最有可能符合产后血栓预防资格,归因于临床风险因素而非遗传性风险因素。
- 迫切需要更好地理解血栓预防使用的种族和民族差异,并公平地处理产后静脉血栓栓塞症的可改变风险因素。
研究设计与样本
- 分析美国全国住院患者样本(National Inpatient Sample)2015年10月至2019年12月的数据,使用诊断和操作代码识别产后个体及其静脉血栓栓塞症风险因素。
- 按种族或民族分层,比较符合美国妇产科医师学会(ACOG)、美国胸科医师学会(ACCP)、英国皇家妇产科医师学院(RCOG)和美国血液学会指南血栓预防资格的住院分娩比例。
主要发现
- 在美国全国估计的14,967,861例住院分娩中,使用RCOG、ACCP、ACOG和美国血液学会指南符合血栓预防资格的比例分别为32.9%、8.0%、0.2%和0.2%。
- 使用RCOG标准,非西班牙裔黑人个体血栓预防资格比例最高(39.7%),西班牙裔个体最低(30.8%)。
- 血栓预防资格的种族差异由临床风险因素(非西班牙裔黑人38.8% vs 西班牙裔30.5%)和剖宫产率(35.9% vs 32.2%)驱动,而非静脉血栓栓塞症病史(0.3% vs 0.1%)、遗传性易栓症(0.2% vs 0.2%)或镰状细胞病(0.4% vs <0.1%)。
关键数值与推荐
- RCOG指南血栓预防资格比例:32.9%。
- ACCP指南血栓预防资格比例:8.0%。
- ACOG指南血栓预防资格比例:0.2%。
- 美国血液学会指南血栓预防资格比例:0.2%。
- 使用RCOG标准,非西班牙裔黑人个体血栓预防资格比例39.7%,西班牙裔个体30.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postpartum venous thromboembolism (VTE) incidence differs by race and ethnicity in the United States. However, it is unclear whether the eligibility criteria for postpartum VTE prophylaxis mirror this disparity. OBJECTIVE: To characterize the prevalence of risk factors and eligibility for postpartum VTE prophylaxis, among US Birthing people, stratified by race and ethnicity. METHODS: We analyzed the National Inpatient Sample from October 2015 to December 2019, using diagnosis and procedure codes to identify postpartum individuals and their VTE risk factors. We compared proportion of delivery hospitalizations meeting eligibility for thromboprophylaxis stratified by race or ethnicity, according to American College of Gynecology and Obstetrics, American College of Chest Physicians, Royal College of Obstetricians and Gynecologists (RCOG), and American Society for Hematology guidelines. RESULTS: Among a national estimate of 14 967 861 delivery hospitalizations in the United States, the proportion of individuals eligible for thromboprophylaxis using the RCOG, American College of Chest Physicians, American College of Gynecology and Obstetrics, and American Society for Hematology guidelines were 32.9%, 8.0%, 0.2%, and 0.2%, respectively. Using the RCOG criteria, non-Hispanic Black individuals had the highest proportion of thromboprophylaxis eligibility (39.7%), whereas it was lowest among Hispanic individuals (30.8%). Racial disparities in thromboprophylaxis eligibility were driven by differences in clinical risk factors (38.8% non-Hispanic Black population vs 30.5% Hispanic population) and cesarean section rates (35.9% vs 32.2%), rather than history of VTE (0.3% vs 0.1%), inherited thrombophilia (0.2% vs 0.2%), or sickle cell disease (0.4% vs <0.1%). CONCLUSION: Non-Hispanic Black individuals were most likely to qualify for postpartum thromboprophylaxis, attributable to clinical risk factors rather than inherited risk factors. An urgent need exists to better understand ethno-racial disparities in thromboprophylaxis use and to equitably address modifiable risk factors for postpartum VTE.
引用
- Campbell AIK, Xu Y, Skeith L, et al. Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States. J Thromb Haemost. 2023. PMID: 37838240. doi:10.1016/j.jtha.2023.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。